KalVista Pharmaceuticals, Inc. Quarterly Accounts Payable, Current in USD from Q4 2014 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary
KalVista Pharmaceuticals, Inc. quarterly Accounts Payable, Current history and growth rate from Q4 2014 to Q2 2024.
  • KalVista Pharmaceuticals, Inc. Accounts Payable, Current for the quarter ending July 31, 2024 was $10.8M, a 113% increase year-over-year.
Accounts Payable, Current, Quarterly (USD)
Accounts Payable, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $10.8M +$5.73M +113% Jul 31, 2024 10-Q 2024-09-05
Q1 2024 $9.11M +$4.29M +89.1% Apr 30, 2024 10-Q 2024-09-05
Q4 2023 $3.1M +$1.4M +82.6% Jan 31, 2024 10-Q 2024-03-11
Q3 2023 $4.9M +$1.51M +44.7% Oct 31, 2023 10-Q 2023-12-07
Q2 2023 $5.06M +$2.15M +74% Jul 31, 2023 10-Q 2023-09-07
Q1 2023 $4.82M +$1.18M +32.4% Apr 30, 2023 10-K 2024-07-11
Q4 2022 $1.7M -$487K -22.3% Jan 31, 2023 10-Q 2023-03-09
Q3 2022 $3.38M +$225K +7.12% Oct 31, 2022 10-Q 2022-12-08
Q2 2022 $2.91M +$1.46M +101% Jul 31, 2022 10-Q 2022-09-08
Q1 2022 $3.64M +$1.66M +83.6% Apr 30, 2022 10-K 2023-07-10
Q4 2021 $2.19M +$1.54M +241% Jan 31, 2022 10-Q 2022-03-10
Q3 2021 $3.16M +$986K +45.4% Oct 31, 2021 10-Q 2021-12-09
Q2 2021 $1.45M -$326K -18.4% Jul 31, 2021 10-Q 2021-09-09
Q1 2021 $1.98M +$304K +18.1% Apr 30, 2021 10-K 2022-07-07
Q4 2020 $641K -$2.31M -78.3% Jan 31, 2021 10-Q 2021-03-11
Q3 2020 $2.17M -$65K -2.9% Oct 31, 2020 10-Q 2020-12-10
Q2 2020 $1.77M -$1.33M -42.8% Jul 31, 2020 10-Q 2020-09-14
Q1 2020 $1.68M -$1.18M -41.4% Apr 30, 2020 10-K 2021-07-13
Q4 2019 $2.95M -$47K -1.57% Jan 31, 2020 10-Q 2020-03-10
Q3 2019 $2.24M -$780K -25.8% Oct 31, 2019 10-Q 2019-12-03
Q2 2019 $3.1M +$758K +32.3% Jul 31, 2019 10-Q 2019-09-09
Q1 2019 $2.86M +$1.43M +99.6% Apr 30, 2019 10-K 2020-07-01
Q4 2018 $3M +$1.42M +90.3% Jan 31, 2019 10-Q 2019-03-14
Q3 2018 $3.02M +$1.98M +190% Oct 31, 2018 10-Q 2018-12-14
Q2 2018 $2.35M +$402K +20.7% Jul 31, 2018 10-Q 2018-09-14
Q1 2018 $1.43M +$280K +24.3% Apr 30, 2018 10-K 2019-07-16
Q4 2017 $1.58M +$820K +109% Jan 31, 2018 10-Q 2018-03-16
Q3 2017 $1.04M +$609K +141% Oct 31, 2017 10-Q 2017-12-14
Q2 2017 $1.94M +$1.76M +939% Jul 31, 2017 10-Q 2017-09-14
Q1 2017 $1.15M +$360K +45.4% Apr 30, 2017 10-K 2018-07-30
Q4 2016 $755K -$705K -48.3% Jan 31, 2017 10-Q 2017-03-16
Q3 2016 $431K -$1.1M -71.8% Sep 30, 2016 10-Q 2016-11-08
Q2 2016 $187K -$1.81M -90.6% Jun 30, 2016 10-Q 2016-08-12
Q1 2016 $793K -$1.75M -68.8% Mar 31, 2016 10-Q 2016-05-12
Q4 2015 $1.46M +$436K +42.6% Dec 31, 2015 10-Q 2016-11-08
Q3 2015 $1.53M Sep 30, 2015 10-Q 2015-11-12
Q2 2015 $1.99M Jun 30, 2015 10-Q 2015-08-13
Q1 2015 $2.55M Mar 31, 2015 10-Q 2015-05-21
Q4 2014 $1.02M Dec 31, 2014 10-K 2016-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.